bexarotene has been researched along with Recrudescence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abboud, CN; Cashen, AF; Dipersio, JF; Jacoby, M; Niu, H; Pusic, I; Schroeder, MA; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Welch, JS; Westervelt, P | 1 |
| Bansal, A; Benoit, B; Cha, XY; Fakharzadeh, SS; Kim, EJ; Lin, JH; Nasta, S; Richardson, SK; Rook, AH; Seykora, J; Wysocka, M; Zafar, S | 1 |
| Berg, SE; Chong, EA; Downs, LH; Schuster, SJ; Torigian, DA; Tsai, DE; Wasik, MA | 1 |
| Chemnitz, J; Kurschat, P; Scheid, C; Schlaak, M; Shimabukuro-Vornhagen, A; Stadler, R; Theurich, S; von Bergwelt-Baildon, M | 1 |
| Demierre, MF; DiVenuti, G; Foss, F | 1 |
| Ardigò, M; Berardesca, E; Cota, C; Marulli, GC; Mastroianni, A | 1 |
2 trial(s) available for bexarotene and Recrudescence
| Article | Year |
|---|---|
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
Topics: Administration, Oral; Aged; Aged, 80 and over; Animals; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Azacitidine; Bexarotene; Decitabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Gene Expression; Gene Expression Profiling; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Mice; Middle Aged; Receptors, Retinoic Acid; Recurrence; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; Tetrahydronaphthalenes; Tumor Cells, Cultured | 2014 |
A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Diphtheria Toxin; Drug Tolerance; Female; Humans; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Receptors, Interleukin-2; Recombinant Fusion Proteins; Recurrence; Skin Neoplasms; Tetrahydronaphthalenes; Up-Regulation | 2005 |
4 other study(ies) available for bexarotene and Recrudescence
| Article | Year |
|---|---|
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.
Topics: Bexarotene; Drug Resistance, Neoplasm; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymph Nodes; Male; Middle Aged; Recurrence; Retinoid X Receptor alpha; Skin Neoplasms; T-Lymphocytes; Tetrahydronaphthalenes | 2008 |
Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cyclophosphamide; Doxorubicin; Humans; Lymphomatoid Granulomatosis; Male; Prednisolone; Prognosis; Recurrence; Remission Induction; Retinoids; Tetrahydronaphthalenes; Treatment Outcome; Vincristine | 2008 |
Donor lymphocyte infusions combined with systemic PUVA/bexarotene as an effective bimodal immunologic approach in a patient with relapsed cutaneous T cell lymphoma after allogeneic stem cell transplantation.
Topics: Adult; Bexarotene; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Lymphocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Photopheresis; PUVA Therapy; Recurrence; Skin Neoplasms; Tetrahydronaphthalenes | 2011 |
Bexarotene and interferon-alpha combination therapy in a patient affected by relapsing anaplastic large cell lymphoma with cutaneous involvement.
Topics: Aged; Bexarotene; Disease-Free Survival; Drug Therapy, Combination; Humans; Interferon-alpha; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Tetrahydronaphthalenes | 2007 |